Challenges in managing osteogenesis imperfecta in a resource-limited setting: a case report by Ssekabembe Richard, Natumanya Robert, Vanusa Da Consolação Sambo, Abonga Daniel, Okidi Ronald

“…Recent research has also explored new therapies, including teriparatide, denosumab, and allele-specific silencing (Edelu et al. in Ann Med Health Sci Res 4(Suppl 1):S1–5, 2014; Bastos et al. in Einstein (São Paulo) 8:480–2, 2010; Van Dijk and Sillence in Am J Med Genet A 164A(6):1470–81, 2014; Subramanian and Viswanathan in Osteogenesis Imperfecta. In: StatPearls. Treasure Island (FL): StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK536957/ . …”
Get full text